UA115121C2 - Сукупність частинок, які містять каротиноїдну сполуку і молекулу, що транспортується, та їх застосування - Google Patents

Сукупність частинок, які містять каротиноїдну сполуку і молекулу, що транспортується, та їх застосування

Info

Publication number
UA115121C2
UA115121C2 UAA201310442A UAA201310442A UA115121C2 UA 115121 C2 UA115121 C2 UA 115121C2 UA A201310442 A UAA201310442 A UA A201310442A UA A201310442 A UAA201310442 A UA A201310442A UA 115121 C2 UA115121 C2 UA 115121C2
Authority
UA
Ukraine
Prior art keywords
particles
carotenoid
incorporation
carotenoid particles
cargo
Prior art date
Application number
UAA201310442A
Other languages
English (en)
Inventor
Іван Петяєв
Original Assignee
Ай Пі САЙЕНС ЛІМІТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ай Пі САЙЕНС ЛІМІТЕД filed Critical Ай Пі САЙЕНС ЛІМІТЕД
Publication of UA115121C2 publication Critical patent/UA115121C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)

Abstract

Винахід стосується сукупності частинок, кожна з яких містить одну або більше каротиноїдних сполук, які утворюють шар, що інкапсулює внутрішнє ядро, яке містить одну або більше число молекул, що транспортуються, причому частинки не містять білка молочної сироватки; фармацевтичної композиції для доставляння молекул, що транспортуються; харчової композиції для доставляння молекул, що транспортуються; способу виготовлення такої харчової композиції; способу поліпшення доставки молекул, що транспортуються, до тканини-мішені; способу лікування серцево-судинних захворювань, підвищених рівнів холестерину, що включає введення вказаної сукупності частинок; застосування вказаної сукупності частинок при виробництві медикаменту; харчового продукту, що містить вказану сукупність частинок.
UAA201310442A 2011-01-31 2012-01-25 Сукупність частинок, які містять каротиноїдну сполуку і молекулу, що транспортується, та їх застосування UA115121C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1101669.8A GB201101669D0 (en) 2011-01-31 2011-01-31 Carotenoid particles and uses thereof
PCT/GB2012/000075 WO2012104576A2 (en) 2011-01-31 2012-01-25 Carotenoid particles and uses thereof

Publications (1)

Publication Number Publication Date
UA115121C2 true UA115121C2 (uk) 2017-09-25

Family

ID=43824892

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201310442A UA115121C2 (uk) 2011-01-31 2012-01-25 Сукупність частинок, які містять каротиноїдну сполуку і молекулу, що транспортується, та їх застосування

Country Status (10)

Country Link
US (3) US20130337068A1 (uk)
EP (1) EP2670392B1 (uk)
JP (2) JP6189219B2 (uk)
CN (2) CN107028936A (uk)
AU (2) AU2012213235B2 (uk)
CA (1) CA2825860A1 (uk)
EA (1) EA201300875A1 (uk)
GB (1) GB201101669D0 (uk)
UA (1) UA115121C2 (uk)
WO (1) WO2012104576A2 (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
CN105517575B (zh) * 2013-09-25 2018-03-09 格力高营养食品株式会社 脂溶性物质的乳化性制剂
CA2933086C (en) 2013-12-11 2019-04-02 Health-Ever Biotech Co. Ltd Pharmaceutical compositions of carotenoid
WO2016098562A1 (ja) * 2014-12-19 2016-06-23 グリコ栄養食品株式会社 π共役系の難溶性又は不溶性物質の可溶化又は分散化組成物
EP3072400B1 (en) * 2015-03-26 2017-10-04 DSM IP Assets B.V. New color for beverages
CN109481450B (zh) * 2015-09-02 2021-07-23 盛世泰科生物医药技术(苏州)有限公司 一种用于预防和治疗白内障的眼用制剂及其制备方法
GB201618350D0 (en) * 2016-10-31 2016-12-14 Ip Science Ltd Methods and compositions comprising carotenoids
BR112019008739A2 (pt) 2016-11-04 2019-07-09 Immd Sp Zo O distribuição inteligente de moléculas ingeridas e absorvidas
WO2018112479A1 (en) 2016-12-16 2018-06-21 Flavorsense Dried flakes with active ingredients
JP6170231B1 (ja) * 2016-12-22 2017-07-26 株式会社タイショーテクノス 色素製剤及びその製造方法、並びに加工製品及びその製造方法
CN108169481B (zh) * 2017-07-27 2023-07-07 河北省中药材质量检验检测研究中心有限公司 一种检测芍药苷的试纸条及其制备方法和应用
GB201801986D0 (en) * 2018-02-07 2018-03-28 Ip Science Ltd Anthocyanins and used thereof
GB201801985D0 (en) * 2018-02-07 2018-03-28 Ip Science Ltd Formulation of carotenoids
TW202027734A (zh) * 2019-04-01 2020-08-01 許悅郎 預防及／或治療失智症之組合物
CN112206204A (zh) * 2019-06-24 2021-01-12 王成 一种中草药提取物纳米制剂的制备及用于治疗过敏性鼻炎
CN110496247B (zh) * 2019-09-17 2021-09-10 南通大学 一种骨再生材料的制备方法
US20220409565A1 (en) * 2019-11-06 2022-12-29 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
WO2021207566A1 (en) * 2020-04-09 2021-10-14 L.E.A.F. Holdings Group Llc Carotenoid solutions and uses thereof
KR102231437B1 (ko) * 2020-09-21 2021-03-24 주식회사 보삼바이오산업 고병원성 조류 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물의 제조방법 및 그를 이용하여 제조한 고병원성 조류 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
FR3117339A1 (fr) * 2020-12-16 2022-06-17 Naos Institute Of Life Science Utilisation des bactériorubérines et leurs dérivés glycosylés pour prévenir et traiter les maladies impliquant une dérégulation de l’agrégation des protéines, comme les maladies neurodégénératives
CN116370324B (zh) * 2023-06-06 2023-08-15 成都普什制药有限公司 一种含有玻尿酸的抗氧化精华液及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081171A (en) * 1959-09-01 1963-03-12 Corn Products Co Stabilization of carotenoid material
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
PL203142B1 (pl) 2000-05-30 2009-08-31 Nestle Sa Kompozycja podstawowa zawierająca bioaktywny związek lipofilowy, sposób jej wytwarzania oraz jej zastosowanie do wytwarzania produktu spożywczego lub dodatku do produktu spożywczego i do wytwarzania kompozycji kosmetycznej
US20050106219A1 (en) * 2000-05-30 2005-05-19 Karlheinz Bortlik Primary composition comprising a lipophilic bioactive compound
KR100426346B1 (ko) * 2000-11-30 2004-04-08 한국화학연구원 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
CN100379425C (zh) * 2002-02-21 2008-04-09 北京龙兴科技股份有限公司 一种改善骨质疏松的组合物
US7182950B2 (en) * 2002-06-12 2007-02-27 Nutralease Ltd. Nano-sized self-assembled liquid dilutable vehicles
CN100475216C (zh) * 2004-08-16 2009-04-08 新疆特丰药业股份有限公司 女用复方番茄红素制剂及其制备工艺
CN100345546C (zh) * 2004-08-25 2007-10-31 浙江震元制药有限公司 氯诺昔康口腔速崩组合物及其制备方法
GB0515035D0 (en) 2005-07-21 2005-08-31 Cambridge Theranostics Ltd Treatment of atherosclerotic conditions
CN100364541C (zh) * 2005-09-13 2008-01-30 河北师范大学 番茄红素脂质体及其制备方法
ES2365246T3 (es) * 2006-03-27 2011-09-27 Nestec S.A. Vehículo de proteína del suero de la leche para el suministro de un agente activo.
EA200802072A1 (ru) * 2006-04-13 2009-04-28 Камедика Лимитед Ликопин для лечения нарушения обмена веществ
CN101453914A (zh) * 2006-04-13 2009-06-10 凯米迪卡有限公司 治疗代谢功能紊乱的番茄红素
EP2061583B1 (en) * 2006-09-14 2019-04-10 Yissum Research Development Company, of The Hebrew University of Jerusalem Organic nanoparticles obtained from microemulsions by solvent evaporation
WO2009093595A1 (ja) * 2008-01-25 2009-07-30 Fujifilm Corporation カロテノイド含有エマルション組成物の製造方法、それにより得られるカロテノイド含有エマルション組成物並びにカロテノイド含有粉末組成物、該組成物を含む機能性食品及び化粧品
CN101590087A (zh) * 2008-05-27 2009-12-02 北京因科瑞斯医药科技有限公司 一种延缓女性衰老的组合物及其制备方法
GB201101669D0 (en) * 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof

Also Published As

Publication number Publication date
US20170304448A1 (en) 2017-10-26
CN103370053A (zh) 2013-10-23
AU2012213235A1 (en) 2013-09-12
US20170049893A1 (en) 2017-02-23
EA201300875A1 (ru) 2014-01-30
WO2012104576A3 (en) 2013-01-03
JP6563447B2 (ja) 2019-08-21
US9737602B2 (en) 2017-08-22
EP2670392A2 (en) 2013-12-11
US20130337068A1 (en) 2013-12-19
JP2014505068A (ja) 2014-02-27
WO2012104576A2 (en) 2012-08-09
CN107028936A (zh) 2017-08-11
AU2017204740A1 (en) 2017-07-27
CN103370053B (zh) 2017-02-15
GB201101669D0 (en) 2011-03-16
JP2018008988A (ja) 2018-01-18
AU2012213235B2 (en) 2017-04-13
CA2825860A1 (en) 2012-08-09
EP2670392B1 (en) 2020-11-11
JP6189219B2 (ja) 2017-08-30

Similar Documents

Publication Publication Date Title
UA115121C2 (uk) Сукупність частинок, які містять каротиноїдну сполуку і молекулу, що транспортується, та їх застосування
WO2013084000A3 (en) Exosomes for delivery of biotherapeutics
WO2011109365A3 (en) Concentrated protein formulations and uses thereof
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
WO2012122535A3 (en) Stable formulations for parenteral injection of peptide drugs
IN2015KN00005A (uk)
WO2012104275A3 (en) Nanoparticles delivery systems, preparation and uses thereof
WO2012174158A3 (en) Administration of benzodiazepine
WO2011116963A3 (en) Lipid nanoparticle capsules
WO2012101639A3 (en) Nanoparticles based for dermal and systemic delivery of drugs
IL231168B (en) Benzenesulfonamide history of quinoxaline, their pharmaceutical preparations and their use for the preparation of a drug for the treatment of cancer
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
WO2012116073A3 (en) Amphiphilic dendron-coils, micelles thereof and uses
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
MX351421B (es) Nuevo sistema de recubrimiento.
EP3449944A4 (en) ORAL ADDED NANOPARTICLES FOR GENERAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION THEREFOR
IL232701A (en) Pirazine compounds that inhibit sick kinase, pharmaceutical preparations that contain them and their use in the preparation of drugs
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
WO2012040331A3 (en) Multistage nanoparticles
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
EP2682102A3 (en) Inhalation Compositions Comprising Corticosteroid and Sorbitol
EP2682098A3 (en) Inhalation Compositions
WO2015003021A3 (en) Dietary supplements and composition for treating cancer
WO2014104989A8 (en) Pharmaceutical compositions comprising aripiprazole